Jpmorgan Chase & CO Asensus Surgical, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Asensus Surgical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 87,506 shares of ASXC stock, worth $30,627. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,506
Previous 69,044
26.74%
Holding current value
$30,627
Previous $15,000
86.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ASXC
# of Institutions
50Shares Held
39.8MCall Options Held
12.4KPut Options Held
0-
Beryl Capital Management LLC Redondo Beach, CA14.5MShares$5.08 Million1.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$4.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.47MShares$1.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.5MShares$874,3530.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA2MShares$700,0000.04% of portfolio
About ASENSUS SURGICAL, INC.
- Ticker ASXC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 236,719,008
- Market Cap $82.9M
- Description
- Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...